Cabangcala, Wilfredo .

HRN: 28-62-80  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/28/2026
03/07/2026
IV
Q8
NKA
Acute Pyelonephritis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: